title: Resting energy expenditure is lower than predicted in people taking atypical antipsychotic medication.
abstract: Resting energy expenditure (REE) is lower than predicted in persons taking atypical antipsychotic medication, and weight management is a significant clinical challenge for some of them. However, to date there have been no published guidelines to assist clinicians in choosing appropriate prediction equations to estimate energy expenditure in persons taking atypical antipsychotic medications. The objectives of this study were to measure REE in a group of men taking the atypical antipsychotic clozapine and to determine whether REE can be accurately predicted for this population using previously published regression equations. REE was measured using indirect calorimetry via a ventilated hood on eight men who had completed at least 6 months of treatment with clozapine. Comparisons between measured REE and predicted REE using five different equations were undertaken. The commonly-used Harris-Benedict and Schofield equations systematically overestimated REE. Predictions of REE from other equations were too variable for clinical use. When estimating energy requirements as part of a weight-management program in men who have been taking clozapine for 6 months, predictions of REE from the equations of Harris-Benedict and Schofield should be reduced by 280 kcal/day.
authors.affiliation: The ParkCentre for Mental Health, Treatment, Research and Education, Walcol, 4077 Queensland, Australia. Jenny-Kay_Sharpe@health.qld.gov.au
authors.forename: Jenny-Kay
authors.initials: JK
authors.lastname: Sharpe
authors.forename: Nuala M
authors.initials: NM
authors.lastname: Byrne
authors.forename: Terry J
authors.initials: TJ
authors.lastname: Stedman
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Hills
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001481:Basal Metabolism / Q000187:drug effects* / Q000502:physiology; D001835:Body Weight / Q000502:physiology; D002153:Calorimetry, Indirect / Q000009:adverse effects; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008433:Mathematics; D011237:Predictive Value of Tests; D012044:Regression Analysis; D012563:Schizophrenia, Paranoid / Q000188:drug therapy / Q000378:metabolism; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine